Report Detail

Pharma & Healthcare Global (United States, European Union and China) Human Vaccines Market Research Report 2019-2025

  • RnM3692377
  • |
  • 23 August, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
In 2019, the market size of Human Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Vaccines.

This report studies the global market size of Human Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech

Market Segment by Product Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Other

Market Segment by Application
Adults
Children

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Human Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Human Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Human Vaccines Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Varicella
      • 1.3.3 Influenza
      • 1.3.4 Polio
      • 1.3.5 Hepatitis A
      • 1.3.6 Rabies
      • 1.3.7 BCG
      • 1.3.8 Hepatitis B
      • 1.3.9 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Human Vaccines Market Share by Application (2019-2025)
      • 1.4.2 Adults
      • 1.4.3 Children
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Human Vaccines Market Size
      • 2.1.1 Global Human Vaccines Revenue 2014-2025
      • 2.1.2 Global Human Vaccines Sales 2014-2025
    • 2.2 Human Vaccines Growth Rate by Regions
      • 2.2.1 Global Human Vaccines Sales by Regions 2014-2019
      • 2.2.2 Global Human Vaccines Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Human Vaccines Sales by Manufacturers
      • 3.1.1 Human Vaccines Sales by Manufacturers 2014-2019
      • 3.1.2 Human Vaccines Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Human Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Human Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Human Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.3 Human Vaccines Price by Manufacturers
    • 3.4 Key Manufacturers Human Vaccines Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Human Vaccines Market
    • 3.6 Key Manufacturers Human Vaccines Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Varicella Sales and Revenue (2014-2019)
      • 4.1.2 Influenza Sales and Revenue (2014-2019)
      • 4.1.3 Polio Sales and Revenue (2014-2019)
      • 4.1.4 Hepatitis A Sales and Revenue (2014-2019)
      • 4.1.5 Rabies Sales and Revenue (2014-2019)
      • 4.1.6 BCG Sales and Revenue (2014-2019)
      • 4.1.7 Hepatitis B Sales and Revenue (2014-2019)
      • 4.1.8 Other Sales and Revenue (2014-2019)
    • 4.2 Global Human Vaccines Sales Market Share by Type
    • 4.3 Global Human Vaccines Revenue Market Share by Type
    • 4.4 Human Vaccines Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Human Vaccines Sales by Application

    6 United States

    • 6.1 United States Human Vaccines Breakdown Data by Company
    • 6.2 United States Human Vaccines Breakdown Data by Type
    • 6.3 United States Human Vaccines Breakdown Data by Application

    7 European Union

    • 7.1 European Union Human Vaccines Breakdown Data by Company
    • 7.2 European Union Human Vaccines Breakdown Data by Type
    • 7.3 European Union Human Vaccines Breakdown Data by Application

    8 China

    • 8.1 China Human Vaccines Breakdown Data by Company
    • 8.2 China Human Vaccines Breakdown Data by Type
    • 8.3 China Human Vaccines Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Human Vaccines Breakdown Data by Company
    • 9.2 Rest of World Human Vaccines Breakdown Data by Type
    • 9.3 Rest of World Human Vaccines Breakdown Data by Application
    • 9.4 Rest of World Human Vaccines Breakdown Data by Countries
      • 9.4.1 Rest of World Human Vaccines Sales by Countries
      • 9.4.2 Rest of World Human Vaccines Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 CNBG
      • 10.1.1 CNBG Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.1.4 Human Vaccines Product Introduction
      • 10.1.5 CNBG Recent Development
    • 10.2 Changsheng Life
      • 10.2.1 Changsheng Life Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.2.4 Human Vaccines Product Introduction
      • 10.2.5 Changsheng Life Recent Development
    • 10.3 Zhifei
      • 10.3.1 Zhifei Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.3.4 Human Vaccines Product Introduction
      • 10.3.5 Zhifei Recent Development
    • 10.4 ChengDa Bio
      • 10.4.1 ChengDa Bio Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.4.4 Human Vaccines Product Introduction
      • 10.4.5 ChengDa Bio Recent Development
    • 10.5 Kangtai
      • 10.5.1 Kangtai Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.5.4 Human Vaccines Product Introduction
      • 10.5.5 Kangtai Recent Development
    • 10.6 SINOVAC BIOTECH
      • 10.6.1 SINOVAC BIOTECH Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.6.4 Human Vaccines Product Introduction
      • 10.6.5 SINOVAC BIOTECH Recent Development
    • 10.7 Hissen
      • 10.7.1 Hissen Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.7.4 Human Vaccines Product Introduction
      • 10.7.5 Hissen Recent Development
    • 10.8 Walvax Biotechnology
      • 10.8.1 Walvax Biotechnology Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.8.4 Human Vaccines Product Introduction
      • 10.8.5 Walvax Biotechnology Recent Development
    • 10.9 GSK
      • 10.9.1 GSK Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.9.4 Human Vaccines Product Introduction
      • 10.9.5 GSK Recent Development
    • 10.10 SANOFI
      • 10.10.1 SANOFI Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Human Vaccines
      • 10.10.4 Human Vaccines Product Introduction
      • 10.10.5 SANOFI Recent Development
    • 10.11 Rong An
    • 10.12 NuoCheng Bio
    • 10.13 Hualan Bio
    • 10.14 Tiantan biological
    • 10.15 Changchun Baike
    • 10.16 Adimmune
    • 10.17 Zhongyianke Biotech

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Human Vaccines Sales Channels
      • 11.2.2 Human Vaccines Distributors
    • 11.3 Human Vaccines Customers

    12 Market Forecast

    • 12.1 Global Human Vaccines Sales and Revenue Forecast 2019-2025
    • 12.2 Global Human Vaccines Sales Forecast by Type
    • 12.3 Global Human Vaccines Sales Forecast by Application
    • 12.4 Human Vaccines Forecast by Regions
      • 12.4.1 Global Human Vaccines Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Human Vaccines Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Human Vaccines. Industry analysis & Market Report on Human Vaccines is a syndicated market report, published as Global (United States, European Union and China) Human Vaccines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Human Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,624.00
      3,936.00
      5,248.00
      3,152.08
      4,728.12
      6,304.16
      500,593.60
      750,890.40
      1,001,187.20
      286,639.20
      429,958.80
      573,278.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report